RECOMBINANT BCG VACCINES FOR THE PREVENTION AND TREATMENT OF CANCER
摘要
<p>The present invention relates to recombinant mycobacteria, particularly recombinant M. bovis, BCG, engineered to express a MUCI polypeptide and human interleukin-2 for use in cancer immunotherapy.</p>
